Allogene Therapeutics Inc (ALLO)

Depreciation & Amortization

$11.67M

TTM · Period ending: · USD

ALLO logo

ALLO Depreciation & Amortization

Latest reported$11.67M
ALLO TTM Depreciation & Amortization ($1.50M → $11.67M)
High-resolution chart · PNG

ALLO depreciation & amortization history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Allogene Therapeutics Inc Depreciation & Amortization — Trailing twelve months (TTM) (USD)
Period endingDepreciation & Amortization (USD)
11,668,000
12,129,000
12,359,000
12,535,000
12,645,000
13,183,000
13,639,000
13,883,000
14,248,000
14,247,000
14,199,000
13,790,000
14,078,000
14,110,000
14,295,000
15,469,000
13,939,000
12,228,000
10,454,000
8,056,000
7,536,000
7,460,000
7,586,000
7,597,000
7,115,000
6,376,000
5,027,000
3,719,000
2,894,000
2,195,000
1,500,000
953,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.